PepsiCo Inc. has successfully defended against a potential trademark infringement lawsuit by Rise Brewing Co., which accused the beverage giant of exploiting the "Rise" brand name for its MTN Dew Rise Energy drink. The Federal court in New York dismissed the case, siding with PepsiCo's argument that there was significant differentiation between the two brands.
The lawsuit will not continue after PepsiCo convinced the court that it should dissolve the suit being lodged by Rise Brewing over allegations that the beverage and snack giant used a similar name, "MTN DEW Rise," for its energy drink. The coffee brewer said PepsiCo is taking advantage of its Rise brand by adding "Rise" to the name of its MTN Dew energy drink.
Rise Brewing explained the energy drink's name is "confusingly similar" to its brand. However, Bloomberg Law reported that the New York federal court sided with PepsiCo and dismissed the trademark infringement claims. The decision comes a year after the court banned Pepsi's "MTN Dew Rise" drinks, but it was lifted on appeal.
The dismissal of the trademark lawsuit against PepsiCo was first reported on Wednesday, Aug. 2. In its argument, PepsiCo said its branding for MTN Dew Rise energy drink differs greatly from Rise's products. It also pointed out that the mere appearance of the drink is nothing like the logos or marks on Rise's coffee drink containers.
With these statements, the U.S. District Court for the Southern District of New York was convinced there was no basis for trademark infringement. Thus, the judge ordered the dissolution of the case.
Finally, Reuters further reported that U.S. District Judge Lorna Schofield explained that Rise could not prove that Pepsi's energy drink product confused consumers. This was a victory for PepsiCo after a previous ruling from the same judge led to the order for Pepsi to stop using the "MTN Dew Rise" name.
Photo by: Pepsico Press Release


Oil Prices Slide on US-Iran Talks, Dollar Strength and Profit-Taking Pressure
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Thailand Inflation Remains Negative for 10th Straight Month in January
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Fed Governor Lisa Cook Warns Inflation Risks Remain as Rates Stay Steady
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Trump’s Inflation Claims Clash With Voters’ Cost-of-Living Reality
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Trump Endorses Japan’s Sanae Takaichi Ahead of Crucial Election Amid Market and China Tensions
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Silver Prices Plunge in Asian Trade as Dollar Strength Triggers Fresh Precious Metals Sell-Off 



